• Jing Xiao, Tianzhu Kong, Chad M McWhinnie, Shuqiao Yao, Xiongzhao Zhu, Shuiping Zhao, and Shu Duan.
• Jing Xiao, MD, PhD Assistant Professor, Beijing Key Laboratory of Learning and Cognition and Department of Psychology, Capital Normal University, Beijing, China. Tianzhu Kong, MS Postgraduate, Beijing Key Laboratory of Learning and Cognition and Department of Psychology, Capital Normal University, Beijing, China. Chad M. McWhinnie, PhD Postdoctor, McLean Hospital, Department of Psychiatry, Harvard Medical School, Boston, Massachusetts. Shuqiao Yao, PhD Director and Professor,Medical Psychological Research Center, Second Xiangya Hospital, Central South University, Changsha, China. Xiongzhao Zhu, PhD Professor, Medical Psychological Research Center, Second Xiangya Hospital, Central South University, Changsha, China. Shuiping Zhao, MD Director and Professor, Department of Cardiology, Second Xiangya Hospital, Central South University, Changsha, China. Shu Duan, MD Professor, Department of Cardiology, Second Xiangya Hospital, Central South University, Changsha, China.
• J Cardiovasc Nurs. 2015 Nov 1; 30 (6): 522-8.

BackgroundIn patients with hypertension, psychosocial factors, such as depressive symptoms and anxiety, are associated with reduced quality of life and triple the risk of nonadherence with medical treatment regimens. Thus, screening tests are crucial to identify patients who may require further assessment and treatment.ObjectivesThe objective of the current study was to test the psychometric properties of the Chinese version of the Mood and Anxiety Symptoms Questionnaire-Short Form (MASQ-SF-C) in patients with essential hypertension.MethodsThe MASQ-SF-C, the Center for Epidemiologic Studies Depression Scale (CES-D), and the State-Trait Anxiety Inventory (STAI) were administered to a convenience sample of 869 hypertensive patients in 4 hospitals. A confirmatory factor analysis was used to test the tripartite model. We evaluate the internal consistency of the MASQ-SF-C and we used the Bland-Altman approach to evaluate convergent validity between the MASQ-SF-C t score and symptoms of (1) depressive symptoms and (2) anxiety.ResultsCronbach's α coefficient for the total MASQ-SF-C was .95, and Cronbach's α coefficients for the 3 subscales were .83 for anhedonic depression (AD), .91 for anxiety arousal (AA), and .94 for general distress (GD), indicating adequate internal consistency reliability. The mean interitem correlation coefficients were as follows: MASQ-SF-C, 0.29; AD, 0.28; AA, 0.38; and GD, 0.40. The 1-month test-retest reliability for the MASQ-SF-C was 0.72. Confirmatory factor analyses indicated that the 3 first-order factors (GD, AD, and AA) fit the data well (nonnormed fit index = 0.953, comparative fit index = 0.936, incremental fit index = 0.936, root-mean-square error of approximation = 0.038).ConclusionsThis study supported the reliability and validity of the MASQ-SF-C, indicating that it can be used for assessing depressive symptoms and anxiety concurrently in Chinese-speaking patients with hypertension.

27 keywords...

hide…